Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

781.30INR
19 Sep 2014
Price Change (% chg)

Rs3.25 (+0.42%)
Prev Close
Rs778.05
Open
Rs787.80
Day's High
Rs789.95
Day's Low
Rs775.65
Volume
16,247
Avg. Vol
50,670
52-wk High
Rs906.90
52-wk Low
Rs642.50

Search Stocks
IPCA Laboratories Limited is a pharmaceutical company. The Company is a manufacturer of active pharmaceutical ingredients (APIs)-Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Furosemide (diuretic), Hydroxychloroquine Sulphate (NSAID), Metoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive) and Pyrantel Salts (anthelmintic). Its formulations basket includes generics for the developed markets and branded formulations for emerging markets. The Company manufactures over 350 formulations in virtually every dosage form: oral solids and liquids, dry powders for suspension, and injectables (liquid and dry). The Company’s subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd., Ipca Pharma Nigeria Ltd., National Druggist (PTY) Ltd and Ipca Pharma (Australia) Pty Ltd.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links

Search Stocks